Context: Two COVID-19 vaccines have been accepted for Phase 3 trials after passing the Phase 1 and Phase 2 trials. Health care workers and vulnerable subjects shall be given priority to join COVID-19 Phase 3 trials.
Reasons for Likelihood of protection from Vaccine-induced immunity
Argument in Favour of Prioritising Vulnerable and Healthcare Workers in Vaccine Trials:
Way Forward:
Conclusion: All around it would be a good idea for healthcare workers and vulnerable subjects to enrol in the COVID-19 vaccine Phase 3 trials in India.